Ziyuan Nie

Dr. Ziyuan Nie


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2020 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
ZNZiyuan Nie
Ziyuan Nie
MZMing-Hui Zhao
Ming-Hui Zhao
BCBao-Qian Cheng
Bao-Qian Cheng
RPRong-Fang Pan
Rong-Fang Pan
TWTianrui Wang
Tianrui Wang
XZXue-Jun Zhang
Xue-Jun Zhang
Background: The roots of Salvia miltiorrhiza are used in traditional Chinese medicine (TCM) and have high medicinal value. Tanshinone IIA (Tan IIA) is the active ingredient of Salvia miltiorrhiza which can inhibit the growth of acute leukemia cell lines in vitro, although the mechanism remains unclear. Methods: CCK-8 assays and BrdU stain were used to evaluate cell proliferation ability. Western blot analysis was used to detect protein expression. miR-497-5p expression level was detected by using qRT-PCR, and Annexin V-FITC/propidium iodide (PI) was used to detect cell apoptosis. Results: Here we reported that Tan IIA could inhibit cell proliferation, induce cell cycle arrest, and promote cell apoptosis in acute myeloid leukemia (AML) cells. Thus, Tan IIA had the anti-cancer activity in AML cell lines, which was likely mediated by up-regulation of miR-497-5p expression. Our data further showed that in AML cells, the same effects were observed with overexpression of miR-497-5p by a miR-497-5p mimic. We demonstrated that Tan IIA could inhibit the expression of AKT3 by up-regulating the expression of miR-497-5p. We subsequently identified that AKT3 was the direct target of miR-497-5p, and that treatment with Tan IIA obviously reversed the effect of treatment with an miR-497-5p inhibitor under harsh conditions. In turn, PCNA expression was increased and cleaved Caspase-3 was suppressed, which contributed to the growth of AML cells. Conclusions: Our results showed that Tan IIA could inhibit cell proliferation in AML cells through miR-497-5p-mediated AKT3 downregulation pathway.

15 June 2022 in Inflammation
Verified
Journal Article
Open access
PDF file
JYJing Yu
Jing Yu
HQHai-Liang Qi
Hai-Liang Qi
HZHong Zhang
Hong Zhang
ZZZi-Yu Zhao
Zi-Yu Zhao
JZJing- Zhao
Jing- Zhao
ZNZiyuan Nie
Ziyuan Nie
The side effects of doxorubicin (Dox) may influence the long-term survival of patients with malignancies. Therefore, it is necessary to clarify the mechanisms generating these side effects induced by Dox and identify effective therapeutic strategies. Here, we found that interleukin-6 (IL-6), interleukin-1β (IL-1β), and tumor necrosis factor-alpha (TNF-α) levels were significantly increased in vascular tissues of Dox-treated mice and Dox-treated vascular smooth muscle cells (VSMCs). Furthermore, we revealed that Dox downregulated the phosphatase and tension homology deleted on chromosome 10 (PTEN) level while upregulated p-AKT and p65 level in VSMCs in vitro. Overexpression of PTEN in VSMCs partly reversed Dox-induced inflammation. Importantly, we demonstrated that Morin could inhibit Dox-induced inflammation by facilitating an increase of PTEN, thus inhibiting the activation of protein kinase B (AKT)/nuclear factor kappa B (NF-κB)/pathway. Additionally, we showed that Morin could reduce the miR-188-5p level, which was increased in Dox-treated VSMCs. Inhibition of miR-188-5p suppressed Dox-induced vascular inflammation in vitro. In conclusion, Morin reduced the Dox-induced vascular inflammatory by moderating the miR-188-5p/PTEN/AKT/NF-κB pathway, indicating that Morin might be a therapeutic agent for overcoming the Dox-induced vascular inflammation.



1 May 2023 in Minerva Medica
Verified
Journal Article
Closed access
YLYaqiong Lu
Yaqiong Lu
LSLi Sun
Li Sun
LYLin Yang
Lin Yang
XLXiaojun Liu
Xiaojun Liu
MLMenghan Liu
Menghan Liu
JLJianmin Luo
Jianmin Luo
Article: The histone deacetylase inhibitor chidamide improve the sensitivity of chronic myelogenous leukemia drug-resistant cells to imatinib by regulating PTPN6 - Minerva Medica 2023 May 17 - Minerva Medica - Journals

11 February 2026 in European Journal of Haematology
Verified
Journal Article
Closed access
ZNZiyuan Nie
Ziyuan Nie
YAYilimunuer Aihemaiti
Yilimunuer Aihemaiti
FMFan‐Qiao Meng
Fan‐Qiao Meng
DZDong‐Feng Zeng
Dong‐Feng Zeng
TGTie‐Jun Gong
Tie‐Jun Gong